230 related articles for article (PubMed ID: 16410551)
21. HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator.
Roussel BD; Mysiorek C; Rouhiainen A; Jullienne A; Parcq J; Hommet Y; Culot M; Berezowski V; Cecchelli R; Rauvala H; Vivien D; Ali C
J Cell Sci; 2011 Jun; 124(Pt 12):2070-6. PubMed ID: 21610098
[TBL] [Abstract][Full Text] [Related]
22. Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+.
O'Kane RL; Viña JR; Simpson I; Zaragozá R; Mokashi A; Hawkins RA
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E412-9. PubMed ID: 16569760
[TBL] [Abstract][Full Text] [Related]
23. Tissue plasminogen activator promotes axonal outgrowth on CNS myelin after conditioned injury.
Minor K; Phillips J; Seeds NW
J Neurochem; 2009 May; 109(3):706-15. PubMed ID: 19220707
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide, S-nitrosylation and neurodegeneration.
Chung KK; Dawson TM; Dawson VL
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(3):247-54. PubMed ID: 16191392
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of albumin on microglia and macrophages; implications for neurodegeneration following blood-brain barrier damage.
Hooper C; Pinteaux-Jones F; Fry VA; Sevastou IG; Baker D; Heales SJ; Pocock JM
J Neurochem; 2009 May; 109(3):694-705. PubMed ID: 19187440
[TBL] [Abstract][Full Text] [Related]
26. Fluvastatin prevents glutamate-induced blood-brain-barrier disruption in vitro.
Kuhlmann CR; Gerigk M; Bender B; Closhen D; Lessmann V; Luhmann HJ
Life Sci; 2008 Jun; 82(25-26):1281-7. PubMed ID: 18534629
[TBL] [Abstract][Full Text] [Related]
27. Contribution of nitric oxide, superoxide anion, and peroxynitrite to activation of mitochondrial apoptotic signaling in hippocampal CA3 subfield following experimental temporal lobe status epilepticus.
Chuang YC; Chen SD; Liou CW; Lin TK; Chang WN; Chan SH; Chang AY
Epilepsia; 2009 Apr; 50(4):731-46. PubMed ID: 19178557
[TBL] [Abstract][Full Text] [Related]
28. Retinal toxicity of commercial tissue plasminogen activator is mediated by the induction of nitric oxide in the mouse retinal primary cells.
Oh HS; Kwon OW; Chung I; Lee SC; Koh HJ; Lee SH; Lee JH
Curr Eye Res; 2005 Apr; 30(4):291-7. PubMed ID: 16020259
[TBL] [Abstract][Full Text] [Related]
29. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II.
Siao CJ; Tsirka SE
J Neurosci; 2002 May; 22(9):3352-8. PubMed ID: 11978811
[TBL] [Abstract][Full Text] [Related]
30. Increased nitric oxide caused by the ketogenic diet reduces the onset time of kainic acid-induced seizures in ICR mice.
Noh HS; Kim DW; Cho GJ; Choi WS; Kang SS
Brain Res; 2006 Feb; 1075(1):193-200. PubMed ID: 16460714
[TBL] [Abstract][Full Text] [Related]
31. Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory.
Benchenane K; Castel H; Boulouard M; Bluthé R; Fernandez-Monreal M; Roussel BD; Lopez-Atalaya JP; Butt-Gueulle S; Agin V; Maubert E; Dantzer R; Touzani O; Dauphin F; Vivien D; Ali C
J Cell Sci; 2007 Feb; 120(Pt 4):578-85. PubMed ID: 17244650
[TBL] [Abstract][Full Text] [Related]
32. tPA in the central nervous system: relations between tPA and cell surface LRPs.
Ortolano S; Spuch C
Recent Pat Endocr Metab Immune Drug Discov; 2013 Jan; 7(1):65-76. PubMed ID: 23231415
[TBL] [Abstract][Full Text] [Related]
33. Altered nitric oxide production in mouse brain after administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridin or methamphetamine.
Halász AS; Pálfi M; Tábi T; Magyar K; Szöko E
Neurochem Int; 2004 Jun; 44(8):641-6. PubMed ID: 15016479
[TBL] [Abstract][Full Text] [Related]
34. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus.
Tsirka SE; Rogove AD; Bugge TH; Degen JL; Strickland S
J Neurosci; 1997 Jan; 17(2):543-52. PubMed ID: 8987777
[TBL] [Abstract][Full Text] [Related]
35. Regional neuropathology following kainic acid intoxication in adult and aged C57BL/6J mice.
Benkovic SA; O'Callaghan JP; Miller DB
Brain Res; 2006 Jan; 1070(1):215-31. PubMed ID: 16403473
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of caveolin-1 and blood-brain barrier breakdown are attenuated by N-acetylcysteine in thiamine deficiency.
Beauchesne E; Desjardins P; Butterworth RF; Hazell AS
Neurochem Int; 2010 Dec; 57(7):830-7. PubMed ID: 20816907
[TBL] [Abstract][Full Text] [Related]
37. Disruption of tissue plasminogen activator gene reduces macrophage migration.
Ling C; Zou T; Hsiao Y; Tao X; Chen ZL; Strickland S; Song H
Biochem Biophys Res Commun; 2006 Oct; 349(3):906-12. PubMed ID: 16978586
[TBL] [Abstract][Full Text] [Related]
38. Clinical implications of the involvement of tPA in neuronal cell death.
Tsirka SE
J Mol Med (Berl); 1997 May; 75(5):341-7. PubMed ID: 9181475
[TBL] [Abstract][Full Text] [Related]
39. Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity.
Liang J; Takeuchi H; Doi Y; Kawanokuchi J; Sonobe Y; Jin S; Yawata I; Li H; Yasuoka S; Mizuno T; Suzumura A
Brain Res; 2008 May; 1210():11-9. PubMed ID: 18410911
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effects of resident microglia following acute brain injury.
Simard AR; Rivest S
J Comp Neurol; 2007 Oct; 504(6):716-29. PubMed ID: 17722035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
